Earnings calls

Zydus Lifesciences Limited concall ledger

Every earnings call for ZYDUSLIFE — management tone, guidance, KPIs and promise tracking, quarter by quarter.

ZYDUSLIFE · 5 transcripts · Healthcare · latest Q4 FY26

Zydus Lifesciences Limited has 5 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.

Q4 FY26Published 24 May 2026Call held 24 May 2026

ZYDUSLIFE Q4 FY26 Earnings Call Transcript & Analysis

FY26 Consolidated Revenue₹27,150 cr+17% YoYFY26 Consolidated EBITDA₹8,480 cr+20% YoYFY26 Consolidated EBITDA Margin31.2%FY26 Adjusted Net Profit₹5,460 cr+15% YoY

FY26 Consolidated Revenue ₹27,150 cr (+17% YoY); FY26 Consolidated EBITDA ₹8,480 cr (+20% YoY); FY26 Consolidated EBITDA Margin 31.2%. FY26 consolidated revenues grew 17% YoY to ₹271.5 billion.

Read full transcript & analysis

Q3 FY26Published 10 Feb 2026Call held 10 Feb 2026

ZYDUSLIFE Q3 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹6,860 cr+30% YoYConsolidated EBITDA₹1,820 cr+31% YoYConsolidated EBITDA Margin26.5%Adjusted Net Profit₹1,110 cr+9% YoY

Consolidated Revenue ₹6,860 cr (+30% YoY); Consolidated EBITDA ₹1,820 cr (+31% YoY); Consolidated EBITDA Margin 26.5% (+0% YoY). Consolidated revenues of ₹68.6 billion, up 30% YoY.

Read full transcript & analysis

Q2 FY26Published 06 Nov 2025Call held 06 Nov 2025

ZYDUSLIFE Q2 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹6,120 cr+17% YoYEBITDA₹2,020 cr+38% YoYEBITDA Margin32.9%+5% YoYNet Profit₹1,260 cr+38% YoY

Consolidated Revenue ₹6,120 cr (+17% YoY); EBITDA ₹2,020 cr (+38% YoY); EBITDA Margin 32.9% (+5% YoY). Consolidated revenues of ₹61.2 billion, up 17% YoY.

Read full transcript & analysis

Q1 FY26Published 12 Aug 2025Call held 12 Aug 2025

ZYDUSLIFE Q1 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹6,570 cr+6% YoYEBITDA₹2,090 crEBITDA Margin31.8%Net Profit₹1,470 cr+3% YoY

Consolidated Revenue ₹6,570 cr (+6% YoY); EBITDA ₹2,090 cr; EBITDA Margin 31.8%. Consolidated revenues of ₹65.7 billion, up 6% YoY.

Read full transcript & analysis

Q4 FY25Published 27 May 2025Call held 27 May 2025

ZYDUSLIFE Q4 FY25 Earnings Call Transcript & Analysis

Consolidated Revenue232.4 billion rupees+19% YoYConsolidated EBITDA70.6 billion rupees+31% YoYEBITDA Margin32.6%Net Profit47.5 billion rupees+22% YoY

Consolidated Revenue (FY25) 232.4 billion rupees (+19% YoY); Consolidated EBITDA (FY25) 70.6 billion rupees (+31% YoY); EBITDA Margin (Q4 FY25) 32.6%. FY25 consolidated revenues grew 19% YoY to ₹232.4 billion.

Read full transcript & analysis